tiprankstipranks
pc:angie

Angiex Inc

Angiex Inc. is a privately held biotech company focused on exploiting newly discovered biological transport mechanisms to develop drugs with revolutionary power over cancer. Based in Cambridge, Mass., the company is developing a portfolio of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) that release therapeutic payloads directly into the nucleus of cells in the tumor environment, enhancing the efficacy and therapeutic margin of conventional ADCs.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$31M
Total Amount Raised$31M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$31M
Latest Funding Amount$31M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 17, 2025
Investment
$31.00M

Related News and Analysis